Virtu Financial LLC Syndax Pharmaceuticals Inc Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$11.39 - $21.67 $136,087 - $258,913	11,948 New	11,948 $258,000
Q1 2023 May 01, 2023	BUY	$20.66 - $28.98 $824,995 - $1.16 Million	39,932 New	39,932 $843,000
Q1 2021 May 19, 2021	SELL	$19.28 - $24.59 $210,672 - $268,694	-10,927 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$15.1 - $26.44 $164,997 - $288,909	10,927 New	10,927 $243,000
Q4 2017 Feb 09, 2018	SELL	$7.8 - $12.94 $139,861 - $232,027	-17,931 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$10.9 - $12.73 $195,447 - $228,261	17,931	17,931 $0

228

89.9M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $802M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.